Luxembourg vs Tanzania: Access to anti-retroviral drugs, male
Luxembourg
83.0%
in 2024
Tanzania
83.0%
in 2024
Luxembourg rank
40th
Tanzania rank
40th
Access to anti-retroviral drugs, male over time
- Luxembourg
- Tanzania
How they compare
Luxembourg currently reports 83.0% against 83.0% in Tanzania, a difference of 0.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Luxembourg ahead.
Luxembourg ranks 40th and Tanzania ranks 40th of 141 countries.
Luxembourg has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Luxembourg | Tanzania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 45.0% | 5.5% | 39.5% | Luxembourg |
| 2010s | 63.6% | 34.9% | 28.7% | Luxembourg |
| 2020s | 78.8% | 72.8% | 6.0% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Luxembourg or Tanzania?
- Luxembourg, at 83.0% against 83.0% in Tanzania as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Luxembourg and Tanzania?
- 0.0%, with Luxembourg ahead.
- How many years of comparable data are there for Luxembourg and Tanzania?
- 25 years are reported by both, from 2000 to 2024.
- How do Luxembourg and Tanzania rank globally for access to anti-retroviral drugs, male?
- Luxembourg ranks 40th and Tanzania ranks 40th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.